digital therapeutics | pharmaphorum

Wednesday 2 April 2025

Channels

Content type

Categories

Categories

Sort by

Order

digital therapeutics

News

digital health app for depression

UK partnership aims to support NHS use of depression app

Otsuka has teamed up with one of the innovation arms of the NHS to explore how a digital therapeutic (DTx) for major depressive disorder (MDD) could be deployed within the health service.

News

Matt Franklin, Akili’s chief executive

Akili lifted by FDA nod for adult ADHD digital therapeutic

Akili’s new era as a subsidiary of Virtual Therapeutics will start with FDA approval of its digital therapeutic for attention-deficit hyperactivity disorder (ADHD) in adults, a key part of

News

Cara Care DTx

Mahana’s DTx for IBS gets permanent reimbursement in Germany

Mahana Therapeutics has been granted permanent reimbursement in Germany for its Cara Care for irritable bowel syndrome (IBS), paving the way for greater patient access to the digital therap

News

Virtual Therapeutics and Akili

Digital therapeutics firm Akili agrees $34 million takeover

In another deal that highlights the pressures facing companies in the digital health sector, Akili Interactive has agreed to go private in a merger with Virtual Therapeuti

News

Click buys Better assets to speed its digital obesity drive

Click buys Better assets to speed its digital obesity drive

Click Therapeutics has snapped up the assets of troubled digital health company Better Therapeutics, including its FDA-approved prescription digital therapeutic (PDT) for

News

Graphite Digital report

Internal budgets ‘holding back pharma’s digital evolution’

Digital investment in the pharma sector is continuing at a steady pace but could fall behind what is needed to deliver true transformation of their businesses.